The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial (Am J Heart 2005;150:189-92)

✍ Scribed by Atul Aggarwal

• Book ID: 116190412
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 44 KB
• Volume: 151
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2005.09.027